Logo image of ALTUV.PA

BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis

EPA:ALTUV - Euronext Paris - Matif - FR0013345493 - Common Stock - Currency: EUR

1.83  +0 (+0.11%)

Fundamental Rating

3

Taking everything into account, ALTUV scores 3 out of 10 in our fundamental rating. ALTUV was compared to 104 industry peers in the Machinery industry. ALTUV has a bad profitability rating. Also its financial health evaluation is rather negative. ALTUV has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALTUV had negative earnings in the past year.
ALTUV had a positive operating cash flow in the past year.
ALTUV had positive earnings in 4 of the past 5 years.
In multiple years ALTUV reported negative operating cash flow during the last 5 years.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

ALTUV has a Return On Assets of -1.05%. This is in the lower half of the industry: ALTUV underperforms 69.23% of its industry peers.
With a Return On Equity value of -2.20%, ALTUV is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
ALTUV has a Return On Invested Capital of 3.09%. This is in the lower half of the industry: ALTUV underperforms 64.42% of its industry peers.
ALTUV had an Average Return On Invested Capital over the past 3 years of 3.61%. This is below the industry average of 8.40%.
Industry RankSector Rank
ROA -1.05%
ROE -2.2%
ROIC 3.09%
ROA(3y)1.43%
ROA(5y)0.84%
ROE(3y)3.37%
ROE(5y)1.86%
ROIC(3y)3.61%
ROIC(5y)N/A
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of ALTUV has declined.
Looking at the Operating Margin, with a value of 4.98%, ALTUV is in line with its industry, outperforming 47.12% of the companies in the same industry.
In the last couple of years the Operating Margin of ALTUV has grown nicely.
ALTUV has a Gross Margin (36.33%) which is in line with its industry peers.
ALTUV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.98%
PM (TTM) N/A
GM 36.33%
OM growth 3Y7.01%
OM growth 5Y113.83%
PM growth 3Y-45.76%
PM growth 5Y-4.93%
GM growth 3Y3.83%
GM growth 5Y-0.91%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

3

2. Health

2.1 Basic Checks

ALTUV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ALTUV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALTUV has been increased compared to 5 years ago.
Compared to 1 year ago, ALTUV has a worse debt to assets ratio.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

ALTUV has an Altman-Z score of 1.45. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
ALTUV has a Altman-Z score (1.45) which is comparable to the rest of the industry.
ALTUV has a debt to FCF ratio of 4.67. This is a neutral value as ALTUV would need 4.67 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.67, ALTUV is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
ALTUV has a Debt/Equity ratio of 0.61. This is a neutral value indicating ALTUV is somewhat dependend on debt financing.
ALTUV has a Debt to Equity ratio (0.61) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.67
Altman-Z 1.45
ROIC/WACC0.48
WACC6.5%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.69 indicates that ALTUV should not have too much problems paying its short term obligations.
ALTUV has a Current ratio of 1.69. This is comparable to the rest of the industry: ALTUV outperforms 58.65% of its industry peers.
A Quick Ratio of 0.83 indicates that ALTUV may have some problems paying its short term obligations.
ALTUV has a worse Quick ratio (0.83) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 0.83
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

3

3. Growth

3.1 Past

ALTUV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -153.38%.
ALTUV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.06% yearly.
The Revenue for ALTUV has decreased by -13.58% in the past year. This is quite bad
ALTUV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.28% yearly.
EPS 1Y (TTM)-153.38%
EPS 3Y-43.81%
EPS 5Y15.06%
EPS Q2Q%-69.42%
Revenue 1Y (TTM)-13.58%
Revenue growth 3Y10.26%
Revenue growth 5Y28.28%
Sales Q2Q%-8.41%

3.2 Future

Based on estimates for the next years, ALTUV will show a decrease in Earnings Per Share. The EPS will decrease by 0.00% on average per year.
Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 1.03% on average per year.
EPS Next Y-54.54%
EPS Next 2Y-4.65%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year-5.83%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.03%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALTUV. In the last year negative earnings were reported.
ALTUV is valuated reasonably with a Price/Forward Earnings ratio of 8.89.
83.65% of the companies in the same industry are more expensive than ALTUV, based on the Price/Forward Earnings ratio.
ALTUV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 8.89
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

ALTUV's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ALTUV is valued cheaper than 94.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.72
EV/EBITDA 8.1
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.65%
EPS Next 3Y0%

2

5. Dividend

5.1 Amount

ALTUV has a Yearly Dividend Yield of 2.50%.
Compared to an average industry Dividend Yield of 2.63, ALTUV pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, ALTUV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

The earnings of ALTUV are negative and hence is the payout ratio. ALTUV will probably not be able to sustain this dividend level.
DP-83.82%
EPS Next 2Y-4.65%
EPS Next 3Y0%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

BIO-UV GROUP SAS

EPA:ALTUV (3/7/2025, 7:00:00 PM)

1.83

+0 (+0.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)09-19 2024-09-19
Earnings (Next)04-03 2025-04-03/amc
Inst Owners5.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.89M
Analysts86.67
Price Target3.67 (100.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP-83.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.11%
PT rev (3m)-0.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-0.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.89
P/S 0.63
P/FCF 4.72
P/OCF 3.74
P/B 0.79
P/tB N/A
EV/EBITDA 8.1
EPS(TTM)-0.07
EYN/A
EPS(NY)0.21
Fwd EY11.24%
FCF(TTM)0.39
FCFY21.19%
OCF(TTM)0.49
OCFY26.74%
SpS2.9
BVpS2.33
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.05%
ROE -2.2%
ROCE 3.84%
ROIC 3.09%
ROICexc 3.3%
ROICexgc 12.94%
OM 4.98%
PM (TTM) N/A
GM 36.33%
FCFM 13.35%
ROA(3y)1.43%
ROA(5y)0.84%
ROE(3y)3.37%
ROE(5y)1.86%
ROIC(3y)3.61%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)15.38%
ROICexgc(5y)N/A
ROCE(3y)4.5%
ROCE(5y)N/A
ROICexcg growth 3Y20.27%
ROICexcg growth 5Y91.44%
ROICexc growth 3Y0.06%
ROICexc growth 5Y106.94%
OM growth 3Y7.01%
OM growth 5Y113.83%
PM growth 3Y-45.76%
PM growth 5Y-4.93%
GM growth 3Y3.83%
GM growth 5Y-0.91%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.67
Debt/EBITDA 3.39
Cap/Depr 37.07%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 116.85%
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 0.83
Altman-Z 1.45
F-Score4
WACC6.5%
ROIC/WACC0.48
Cap/Depr(3y)75.44%
Cap/Depr(5y)101.31%
Cap/Sales(3y)5.68%
Cap/Sales(5y)7.19%
Profit Quality(3y)1175.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.38%
EPS 3Y-43.81%
EPS 5Y15.06%
EPS Q2Q%-69.42%
EPS Next Y-54.54%
EPS Next 2Y-4.65%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.58%
Revenue growth 3Y10.26%
Revenue growth 5Y28.28%
Sales Q2Q%-8.41%
Revenue Next Year-5.83%
Revenue Next 2Y-0.73%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
EBIT growth 1Y-29.85%
EBIT growth 3Y18%
EBIT growth 5Y174.31%
EBIT Next Year62.65%
EBIT Next 3Y23.12%
EBIT Next 5YN/A
FCF growth 1Y315.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.1%
OCF growth 3YN/A
OCF growth 5YN/A